Taysha Gene Valuation
| TSHA Stock | USD 1.93 0.05 2.66% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Taysha Gene Therapies has a current Real Value of $3.06 per share. The regular price of the company is $1.93. Our model measures the value of Taysha Gene Therapies from inspecting the company fundamentals such as Return On Equity of -1.15, shares outstanding of 204.94 M, and Operating Margin of (11.78) % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Taysha Gene's valuation include:
Price Book 4.339 | Enterprise Value | Enterprise Value Ebitda (0.61) | Price Sales 39.8931 | Trailing PE 3.0635 |
Undervalued
Today
Please note that Taysha Gene's price fluctuation is dangerous at this time. Calculation of the real value of Taysha Gene Therapies is based on 3 months time horizon. Increasing Taysha Gene's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Taysha Gene is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Taysha Stock. However, Taysha Gene's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.93 | Real 3.06 | Target 6.59 | Hype 2.0 | Naive 2.65 |
The real value of Taysha Stock, also known as its intrinsic value, is the underlying worth of Taysha Gene Therapies Company, which is reflected in its stock price. It is based on Taysha Gene's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Taysha Gene's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Taysha Gene Therapies helps investors to forecast how Taysha stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Taysha Gene more accurately as focusing exclusively on Taysha Gene's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Taysha Gene's intrinsic value based on its ongoing forecasts of Taysha Gene's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Taysha Gene's closest peers. If more than one evaluation category is relevant for Taysha Gene we suggest using both methods to arrive at a better estimate.
Taysha Gene Cash |
|
Taysha Valuation Trend
Comparing Taysha Gene's enterprise value against its market capitalization is a good way to estimate the value of Taysha Gene Therapies uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Taysha Gene Total Value Analysis
Taysha Gene Therapies is at this time forecasted to have valuation of 290.14 M with market capitalization of 395.54 M, debt of 61.11 M, and cash on hands of 66.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Taysha Gene fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
290.14 M | 395.54 M | 61.11 M | 66.24 M |
Taysha Gene Investor Information
About 18.0% of the company outstanding shares are owned by corporate insiders. The book value of Taysha Gene was at this time reported as 0.33. The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Taysha Gene's historical financial statements, Taysha Gene Therapies is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.Taysha Gene Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Taysha Gene has an asset utilization ratio of 8.95 percent. This suggests that the Company is making $0.0895 for each dollar of assets. An increasing asset utilization means that Taysha Gene Therapies is more efficient with each dollar of assets it utilizes for everyday operations.Taysha Gene Ownership Allocation
Taysha Gene Therapies shows a total of 204.94 Million outstanding shares. The majority of Taysha Gene Therapies outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Taysha Gene to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Taysha Gene Therapies. Please pay attention to any change in the institutional holdings of Taysha Gene Therapies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Taysha Gene Profitability Analysis
The company reported the previous year's revenue of 15.45 M. Net Loss for the year was (111.57 M) with profit before overhead, payroll, taxes, and interest of 2.5 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Taysha Gene's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Taysha Gene and how it compares across the competition.
About Taysha Gene Valuation
The stock valuation mechanism determines Taysha Gene's current worth on a weekly basis. Our valuation model uses a comparative analysis of Taysha Gene. We calculate exposure to Taysha Gene's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Taysha Gene's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 17.8 M | 18.7 M | |
| Pretax Profit Margin | (6.50) | (6.82) | |
| Operating Profit Margin | (4.22) | (4.43) | |
| Net Loss | (6.50) | (6.82) |
Taysha Gene Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 116.1 M |
Taysha Gene Current Valuation Indicators
Valuation refers to the process of determining the present value of Taysha Gene Therapies and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Taysha we look at many different elements of the entity such as Taysha's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Taysha Gene, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Taysha Gene's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Taysha Gene's worth.Complementary Tools for Taysha Stock analysis
When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |